To: "Voss, Brian Douglas" cc: "Cate, Beth Ellen" , "Martin, Steven A" Subject: Re: Conflicts Management Plan update In-reply-to: Your message of "Wed, 12 Feb 2003 21:48:59 EST." <806C1787BDABE345AF4070C0DE5BF504AA7E92@iu-mssg-mbx05.exchange.iu.edu> Date: Wed, 12 Feb 2003 22:43:25 -0500 From: Geoffrey Fox I can't find Beth's original e-mail in my mailbox -- I'm not sure why Here are answers using Brian's response > This is a multi-part message in MIME format. > > ------_=_NextPart_001_01C2D30A.7553637D > Content-Type: text/plain; > charset="US-ASCII" > Content-Transfer-Encoding: quoted-printable > > Beth, > > =20 > > I think I can answer the third question ... unless I'm missing > something. Lilly funds the Pervasive Technology Labs through the > original grant that founded them. I believe that is what Dr. Fox is > referring to in his disclosure. I'm pretty sure there is no other Lilly > funding involved in his research. Geoffrey, that is correct, isn't it? This is correct > > =20 > > =20 > > -Brian > > =20 > > -----Original Message----- > From: Cate, Beth Ellen=20 > Sent: Wednesday, February 12, 2003 7:57 PM > To: Fox, Geoffrey C. > Cc: Voss, Brian Douglas; Martin, Steven A > Subject: Conflicts Management Plan update > > =20 > > Hi Geoffrey, > > =20 > > I've gone through your updated conflicts disclosure and am making some > corresponding revisions to your management plan, and I had a couple of > questions to make sure I'm tracking: > > =20 > > 1. You indicate that 3CV had no activity last year; does this > mean that you did not end up doing any of the consulting or proposal > reviews last year that were provided for in your 3CV agreement, but that > you are still under contract with them to do that sort of activity in > the coming year? Do you continue to hold equity in 3CV that is equal to > or greater than 5% or $10,000? Has your consulting income from them > stayed the same? I have never received any money from 3CV and never done any work for them so far (so income stayed same as zero ...) They have assembled a team (including me) and are trying to take next step in rather difficult times for such things! I would be surprised if they survive > > =20 > > 2. You mentioned receiving no compensation from Anabas in > 2002-do you still hold an equity interest in that company that is equal > to or greater than 5% or $10,000? =20 Well Anabas would like to think their net worth is such that I hold > $10,000 Anabas was assigned a typical valuation ($10M) when they got their first round of venture capital in around September 2000. My founders shares are then worth some $75000 but there are usual provisos as to reality of this valuation in today's difficult times > > =20 > > 3. You listed Lilly Foundation as a source of research > funding-can you briefly describe the research activity the Foundation is > funding? I'm assuming the NCSA and MSU grants are the same ones > mentioned in your existing conflicts management plan; is that right? You are correct! NCSA MSU are essentially same as before Brian answered Lilly above > > =20 > > Thanks Geoffrey-once I have the revisions ready, I'll send an updated > plan to you and Brian to review. =20 Hope this is OK! Thank you Geoffrey > > =20 > > Beth > > =20 > > Beth Cate > > Associate University Counsel and > > Special Assistant for Policy and Procedures, > > Office of Research and the University Graduate School > > Indiana University > > Bryan Hall 211 > > (812) 855-9739 (phone) > > (812) 855-0678 (fax) > > becate@indiana.edu > > =20 > > =20 > > > ------_=_NextPart_001_01C2D30A.7553637D > Content-Type: text/html; > charset="US-ASCII" > Content-Transfer-Encoding: quoted-printable > > > > > charset=3Dus-ascii"> > > > > > > > > > > >

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>Beth,

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>I think I can answer the third = > question … > unless I’m missing something. Lilly funds the Pervasive = > Technology Labs > through the original grant that founded them. I believe that is = > what Dr. Fox > is referring to in his disclosure. I’m pretty sure there is = > no other > Lilly funding involved in his research. Geoffrey, that is correct, = > isn’t > it?

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>-Brian

> >

style=3D'font-size: > 10.0pt;font-family:Arial;color:navy'>

> >

face=3DTahoma> style=3D'font-size:10.0pt;font-family:Tahoma'>-----Original = > Message-----
> From: Cate, Beth Ellen = >
> Sent: Wednesday, February = > 12, 2003 > 7:57 PM
> To: Fox, Geoffrey C.
> Cc: Voss, Brian Douglas; = > Martin, > Steven A
> Subject: Conflicts = > Management Plan > update

> >

face=3D"Times New Roman"> style=3D'font-size:12.0pt'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"'>Hi = > Geoffrey,

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"'>I’ve gone = > through > your updated conflicts disclosure and am making some corresponding = > revisions to > your management plan, and I had a couple of questions to make sure = > I’m > tracking:

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>1. You = > indicate > that 3CV had no activity last year; does this mean that you did not end = > up > doing any of the consulting or proposal reviews last year that were = > provided > for in your 3CV agreement, but that you are still under contract with = > them to > do that sort of activity in the coming year? Do you continue to = > hold equity in > 3CV that is equal to or greater than 5% or $10,000? Has your = > consulting income > from them stayed the same?

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>2. You mentioned > receiving no compensation from Anabas in 2002—do you still hold an = > equity > interest in that company that is equal to or greater than 5% or = > $10,000?

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>3. You listed > Lilly Foundation as a source of research funding—can you briefly = > describe > the research activity the Foundation is funding? I’m = > assuming the NCSA > and MSU grants are the same ones mentioned in your existing conflicts > management plan; is that right?

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"'>Thanks = > Geoffrey—once > I have the revisions ready, I’ll send an updated plan to you and = > Brian to > review.

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>Beth

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS"'>

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Beth Cate

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Associate face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'> Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS";color:teal'>University size=3D2 color=3Dteal face=3D"Comic Sans MS"> style=3D'font-size:10.0pt; > font-family:"Comic Sans MS";color:teal'> Counsel and

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Special Assistant for Policy and = > Procedures,

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Office of Research and the color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>University face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'> Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans = > MS";color:teal'>Graduate size=3D2 color=3Dteal face=3D"Comic Sans MS"> style=3D'font-size:10.0pt; > font-family:"Comic Sans MS";color:teal'> color=3Dteal face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family: > "Comic Sans MS";color:teal'>School

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Indiana face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS";color:teal'> = > size=3D2 color=3Dteal face=3D"Comic Sans MS"> style=3D'font-size:10.0pt; > font-family:"Comic Sans MS";color:teal'>University

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>Bryan Hall 211

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>(812) 855-9739 (phone)

> >

> >

> >

color=3Dteal > face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"; > color:teal'>(812) 855-0678 (fax)

> >

> >

> >

face=3D"Comic Sans MS"> style=3D'font-size:10.0pt;font-family:"Comic Sans MS"'> href=3D"mailto:becate@indiana.edu">becate@indiana.edu p> > >

> >

> >

face=3D"Times New Roman"> style=3D'font-size:12.0pt'>

> >

> >

face=3D"Times New Roman"> style=3D'font-size:12.0pt'>

> >

> > > > > =00 > ------_=_NextPart_001_01C2D30A.7553637D-- Geoffrey Fox gcf@indiana.edu FAX 8128567972 Phones Cell 315-254-6387 Home 8123239196 Lab 8128567977 CS 8128553788